Literature DB >> 16113345

The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A.

Sandra G Morrison1, Richard P Morrison.   

Abstract

The resolution of primary and secondary chlamydial genital infection in immunoglobulin A (IgA)-deficient (IgA(-/-)) mice was not different from that in IgA(+/+) mice. Furthermore, depletion of either CD4(+) or CD8(+) T cells prior to reinfection of IgA(+/+) or (-/-) mice had limited impact on immunity to reinfection. Thus, although antibody contributes importantly to immunity to chlamydial genital tract reinfection, IgA antibodies are not an absolute requirement of that protective response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113345      PMCID: PMC1231110          DOI: 10.1128/IAI.73.9.6183-6186.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.

Authors:  Yongxin Zhang; Susan Pacheco; Catherine L Acuna; Kirsten C Switzer; Ying Wang; Xyanthine Gilmore; Gregory R Harriman; Innocent N Mbawuike
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Authors:  S G Morrison; H Su; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.

Authors:  R G Rank; H J White; A L Barron
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

5.  Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.

Authors:  Y X Zhang; S Stewart; T Joseph; H R Taylor; H D Caldwell
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

7.  Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix.

Authors:  R C Brunham; C C Kuo; L Cles; K K Holmes
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis.

Authors:  A L Barron; H J White; R G Rank; B L Soloff; E B Moses
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

9.  In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein.

Authors:  R Peeling; I W Maclean; R C Brunham
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice.

Authors:  Ashlesh K Murthy; Jyotika Sharma; Jacqueline J Coalson; Guangming Zhong; Bernard P Arulanandam
Journal:  Cell Immunol       Date:  2004-07       Impact factor: 4.868

View more
  17 in total

Review 1.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Chlamydia-Specific IgA Secretion in the Female Reproductive Tract Induced via Per-Oral Immunization Confers Protection against Primary Chlamydia Challenge.

Authors:  Nita Shillova; Savannah E Howe; Besmir Hyseni; Deahneece Ridgell; Derek J Fisher; Vjollca Konjufca
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

3.  Infection of Hysterectomized Mice with Chlamydia muridarum and Chlamydia trachomatis.

Authors:  Chunfu Yang; William M Whitmire; Gail L Sturdevant; Kevin Bock; Ian Moore; Harlan D Caldwell
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

4.  Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.

Authors:  Sandra G Morrison; Christina M Farris; Gail L Sturdevant; William M Whitmire; Richard P Morrison
Journal:  J Infect Dis       Date:  2011-02-14       Impact factor: 5.226

5.  CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.

Authors:  Christina M Farris; Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

6.  Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Authors:  Anja Weinreich Olsen; Michael Theisen; Dennis Christensen; Frank Follmann; Peter Andersen
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

7.  Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Authors:  Rhea N Coler; Ajay Bhatia; Jean-Francois Maisonneuve; Peter Probst; Brenda Barth; Pamela Ovendale; Hang Fang; Mark Alderson; Yves Lobet; Joe Cohen; Pascal Mettens; Steven G Reed
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

8.  A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.

Authors:  Ashlesh K Murthy; Bharat K R Chaganty; Weidang Li; M Neal Guentzel; James P Chambers; J Seshu; Guangming Zhong; Bernard P Arulanandam
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

9.  Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.

Authors:  Chunmei Cheng; Ilham Bettahi; Maria I Cruz-Fisher; Sukumar Pal; Pooja Jain; Zhenyu Jia; Jan Holmgren; Ali M Harandi; Luis M de la Maza
Journal:  Vaccine       Date:  2009-08-15       Impact factor: 3.641

10.  Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections.

Authors:  Charles W Armitage; Connor P O'Meara; Marina C G Harvie; Peter Timms; Odilia L Wijburg; Kenneth W Beagley
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.